Back to User profile » Dr Mark A Giembycz
Paper published by Dr Mark A Giembycz:
Review
Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD
Mark A Giembycz, Stephen K Field
Drug Design, Development and Therapy 2010, 4:147-158
Published Date: 14 July 2010